Listen Now

Phastar and Medrio have been partnering together on trials for the past 3 years, culminating in a unique way to visualize clinical trial data. Through the use of Medrio’s API, Phastar has built a data visualization tool that reduces risk and allows for complete study oversight. In this podcast we’ll discuss the need for data visualization in clinical trials, how Phastar has continued their trials during a global pandemic, and what their thoughts are on the future of how we collect and view data. 

Quartesian and Medrio have had a solid partnership since 2010 and have partnered together in over 150 studies. In this podcast, we’ll discuss the foundation of our successful partnership, eSource, and the innovative ways we are collaborating with Quarteisan on a COVID-19 study currently underway.

Welcome to the Trial Talks podcast, a thought-provoking show about clinical research. On this podcast, we will be exploring trends in the industry as well as the changing landscape, pandemic impact, various types of research, and more. Today, I’ll be talking with Donna Chang, the CEO and founder of Hope Biosciences. Hope Biosciences focuses on stem cell research to prevent disease and degeneration. In this episode we will be talking about the progress that has been made in the last decade, with regards to stem cell research. We’ll also be talking about stem cell research and COVID-19.  Talking Points: What is Donna Chang’s background and how did Hope Biosciences start? What has been happening in stem cell research in the last 5 - 10 years? The Golden Age of Life Sciences How this research applies to COVID-19 Getting studies up and running for COVID-19 (and other challenges) Other studies and trials that Hope Biosciences is working on The future trends of trials and the long term goals for Hope Biosciences Resources/Links: Official website: Hope Biosciences

Due to COVID-19 the clinical trial industry has been adopting advanced clinical trial technology at warp speed, but what does this mean for the future? What is a sustainable approach to ensure the industry does not face the same challenges and delays should we be impacted by another pandemic or global crisis? In this podcast we sit down with Mary Mattes, Senior Vice President of Global Operations at Synteract to discuss decentralization of clinical trials and a hybrid model.

Australia and New Zealand have not been impacted as much as North America and the EU with regards to COVID-19. For this reason, and their quick study-start timelines, this region could become very attractive to sponsors in the near future. In this podcast, Yvonne Lungershausen and Sandrien Louwaars discuss how Avance Clinical prepared for the pandemic, what tools they implemented that allowed trial continuation, and why clinical trials are currently thriving in the region.